Published in Cancer Epidemiol Biomarkers Prev on June 01, 1997
Folate production by bifidobacteria as a potential probiotic property. Appl Environ Microbiol (2006) 1.08
Folate transport gene inactivation in mice increases sensitivity to colon carcinogenesis. Cancer Res (2005) 1.00
Colon cancer screening and surveillance in inflammatory bowel disease. Clin Endosc (2014) 0.95
The remarkable capacity for gut microbial and host interactions. Gut Microbes (2011) 0.90
Chemoprevention of colorectal cancer in ulcerative colitis. Int J Colorectal Dis (2003) 0.85
DNA methylation in inflammatory bowel disease and beyond. World J Gastroenterol (2013) 0.84
Effect of folate supplementation on mucosal cell proliferation in high risk patients for colon cancer. Gut (2002) 0.83
Genetic variants in 3'-UTRs of methylenetetrahydrofolate reductase (MTHFR) predict colorectal cancer susceptibility in Koreans. Sci Rep (2015) 0.78
Use of a novel genetic mouse model to investigate the role of folate in colitis-associated colon cancer. J Nutr Biochem (2008) 0.77
Host-microbial Cross-talk in Inflammatory Bowel Disease. Immune Netw (2017) 0.75
Oral bacteriotherapy as maintenance treatment in patients with chronic pouchitis: a double-blind, placebo-controlled trial. Gastroenterology (2000) 5.34
Effect of butyrate enemas on the colonic mucosa in distal ulcerative colitis. Gastroenterology (1992) 4.19
European evidence based consensus on the diagnosis and management of Crohn's disease: current management. Gut (2006) 3.59
Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease. N Engl J Med (1996) 3.47
Persistent hepatitis C viraemia without liver disease. Lancet (1993) 3.14
Once daily high dose probiotic therapy (VSL#3) for maintaining remission in recurrent or refractory pouchitis. Gut (2004) 3.01
Echinacea for upper respiratory infection. J Fam Pract (1999) 2.49
Macrophage subpopulations in lamina propria of normal and inflamed colon and terminal ileum. Gut (1989) 2.44
Modulation of human dendritic cell phenotype and function by probiotic bacteria. Gut (2004) 2.29
Impact on the composition of the faecal flora by a new probiotic preparation: preliminary data on maintenance treatment of patients with ulcerative colitis. Aliment Pharmacol Ther (1999) 2.26
Quality of life and length of survival in advanced cancer patients on home parenteral nutrition. Clin Nutr (2002) 2.12
Co-expression of myeloid antigens in childhood acute lymphoblastic leukaemia: relationship with the stage of differentiation and clinical significance. Br J Haematol (1991) 2.08
Prospective trial of adipose-derived regenerative cell (ADRC)-enriched fat grafting for partial mastectomy defects: the RESTORE-2 trial. Eur J Surg Oncol (2012) 2.08
Multicentre comparative study of two schedules of gabexate mesilate in the treatment of acute pancreatitis. Italian Acute Pancreatitis Study Group. Dig Liver Dis (2001) 1.99
Bacteria as the cause of ulcerative colitis. Gut (2001) 1.96
High level of physical activity preserves the cardioprotective effect of preinfarction angina in elderly patients. J Am Coll Cardiol (2001) 1.75
Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73
Oral 5-aminosalicylic acid (Asacol) in the maintenance treatment of Crohn's disease. The Italian IBD Study Group. Gastroenterology (1992) 1.72
Adhesion, autoaggregation and hydrophobicity of 13 strains of Bifidobacterium longum. Lett Appl Microbiol (2000) 1.70
Enhanced mucosal interleukin-6 and -8 in Helicobacter pylori-positive dyspeptic patients. Am J Gastroenterol (1994) 1.69
Increased expression of IP-10, IL-8, MCP-1, and MCP-3 in ulcerative colitis. Am J Pathol (1999) 1.62
Interaction of probiotic Lactobacillus and Bifidobacterium strains with human intestinal epithelial cells: adhesion properties, competition against enteropathogens and modulation of IL-8 production. Int J Food Microbiol (2008) 1.61
Steroid treatment in active Crohn's disease: a comparison between two regimens of different duration. Aliment Pharmacol Ther (1994) 1.59
Home parenteral nutrition in adults: a multicentre survey in Europe in 1993. Clin Nutr (1996) 1.58
High eradication rates of Helicobacter pylori with a new sequential treatment. Aliment Pharmacol Ther (2003) 1.57
Selective growth response to IL-3 of a human leukaemic cell line with megakaryoblastic features. Br J Haematol (1988) 1.55
A pilot study of combination therapy with ribavirin plus interferon alfa for interferon alfa-resistant chronic hepatitis C. Gastroenterology (1994) 1.53
Prospective screening of dyspeptic patients by Helicobacter pylori serology: a safe policy? The Italian Helicobacter pylori Study Group. Endoscopy (1997) 1.52
Apoptosis and human diseases: mitochondrion damage and lethal role of released cytochrome C as proapoptotic protein. Curr Med Chem (2009) 1.51
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis. Aliment Pharmacol Ther (2007) 1.49
Serum ghrelin concentration and weight gain in healthy term infants in the first year of life. J Pediatr Gastroenterol Nutr (2005) 1.48
Lipid peroxidation and antioxidant status in adults receiving lipid-based home parenteral nutrition. Am J Clin Nutr (1998) 1.47
Porcine small intestinal submucosa is not an ideal graft material for Peyronie's disease surgery. J Urol (2006) 1.45
Oral and topical 5-aminosalicylic acid (mesalazine) in inducing and maintaining remission in mild-moderate relapse of ulcerative colitis: one-year randomised multicentre trial. Dig Liver Dis (2002) 1.44
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study. Dig Liver Dis (2007) 1.43
Expression of cytokines, inducible nitric oxide synthase, and matrix metalloproteinases in pouchitis: effects of probiotic treatment. Am J Gastroenterol (2001) 1.43
Serum interleukin 6 in the prognosis of acute biliary pancreatitis. Ital J Gastroenterol Hepatol (1998) 1.42
Cancer surveillance in ulcerative colitis: critical analysis of long-term prospective programme. Dig Liver Dis (2002) 1.42
Review article: the management of refractory Crohn's disease. Aliment Pharmacol Ther (2002) 1.41
Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study. Ital J Gastroenterol Hepatol (1999) 1.41
Probiotics in inflammatory bowel disease: new insight to pathogenesis or a possible therapeutic alternative? Gastroenterology (1999) 1.40
Helicobacter pylori infection and gastric function in patients with chronic idiopathic dyspepsia. Gastroenterology (1992) 1.40
Cell proliferation and ultrastructural changes of the duodenal mucosa of patients affected by familial adenomatous polyposis. Hum Pathol (2004) 1.39
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. Gut (2006) 1.36
Congestive heart failure and cognitive impairment in an older population. Osservatorio Geriatrico Campano Study Group. J Am Geriatr Soc (1998) 1.35
Dilated intercellular spaces as a marker of oesophageal damage: comparative results in gastro-oesophageal reflux disease with or without bile reflux. Aliment Pharmacol Ther (2003) 1.33
Genetic analysis in Italian families with inflammatory bowel disease supports linkage to the IBD1 locus--a GISC study. Eur J Hum Genet (1999) 1.32
Alternative medicine use in HIV-positive men and women: demographics, utilization patterns and health status. AIDS Care (2001) 1.30
Rifaximin in patients with moderate or severe ulcerative colitis refractory to steroid-treatment: a double-blind, placebo-controlled trial. Dig Dis Sci (1999) 1.29
Preconditioning does not prevent postischemic dysfunction in aging heart. J Am Coll Cardiol (1996) 1.28
Upregulation of miR-21 by Ras in vivo and its role in tumor growth. Oncogene (2010) 1.25
Mycophenolate mofetil (MMF) as therapy for refractory chronic GVHD (cGVHD) in children receiving bone marrow transplantation. Bone Marrow Transplant (2000) 1.24
Prevalence of peptic ulcer in Helicobacter pylori positive blood donors. Gut (1994) 1.22
Effects of sildenafil on esophageal motility of patients with idiopathic achalasia. Gastroenterology (2000) 1.21
The treatment of functional dyspepsia with red pepper. Aliment Pharmacol Ther (2002) 1.20
Review article:invasive and non-invasive tests for Helicobacter pylori infection. Aliment Pharmacol Ther (2000) 1.19
Angina-induced protection against myocardial infarction in adult and elderly patients: a loss of preconditioning mechanism in the aging heart? J Am Coll Cardiol (1997) 1.19
Omeprazole, Helicobacter pylori, gastritis, and duodenal ulcer. Lancet (1989) 1.19
Familial expression of anti-Saccharomyces cerevisiae Mannan antibodies in Crohn's disease and ulcerative colitis: a GISC study. Am J Gastroenterol (2001) 1.17
Serum interleukin-6, interleukin-8, and beta 2-microglobulin in early assessment of severity of acute pancreatitis. Comparison with serum C-reactive protein. Dig Dis Sci (1995) 1.17
Relapsing ulcerative colitis after spinal cord stimulation: a case of intestinal neurogenic inflammation? Gastroenterology (1999) 1.16
Rectal dialysate and fecal concentrations of neutrophil gelatinase-associated lipocalin, interleukin-8, and tumor necrosis factor-alpha in ulcerative colitis. Am J Gastroenterol (1999) 1.16
Topical administration of 5-aminosalicylic acid enemas in patients with ulcerative colitis. Studies on rectal absorption and excretion. Gut (1985) 1.15
Effect of probiotic strains on interleukin 8 production by HT29/19A cells. Am J Gastroenterol (2002) 1.15
Serum immunoglobulins in homozygous beta-thalassemia. Acta Haematol (1981) 1.14
Analysis of immune reconstitution in children undergoing cord blood transplantation. Exp Hematol (2001) 1.14
Extramammary Paget's disease of the penis and scrotum: excision, reconstruction and evaluation of occult malignancy. J Urol (2001) 1.13
Fat-induced ileal brake in humans: a dose-dependent phenomenon correlated to the plasma levels of peptide YY. Gastroenterology (1993) 1.13
Gastric secretion and emptying of liquids in reflex esophagitis. Dig Dis Sci (1981) 1.11
Rectal cell proliferation and colon cancer risk in patients with hypergastrinaemia. Gut (1997) 1.09
Local injection of Infliximab for the treatment of perianal Crohn's disease. Dis Colon Rectum (2005) 1.09
Secretory phospholipases A2 induce beta-glucuronidase release and IL-6 production from human lung macrophages. J Immunol (2000) 1.08
Pregnancy outcome in inflammatory bowel disease: prospective European case-control ECCO-EpiCom study, 2003-2006. Aliment Pharmacol Ther (2011) 1.07
Four-week open-label trial of metronidazole and ciprofloxacin for the treatment of recurrent or refractory pouchitis. Aliment Pharmacol Ther (2002) 1.07
Review article: diagnosis of Helicobacter pylori infection. Aliment Pharmacol Ther (2002) 1.07
Serum interleukin-10 in human acute pancreatitis. Dig Dis Sci (1997) 1.06
Mucosal concentrations of interleukin-1 beta, interleukin-6, interleukin-8, and tumor necrosis factor-alpha in pelvic ileal pouches. Dig Dis Sci (1994) 1.05
Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol (2003) 1.04
Total parenteral nutrition-related gastroenterological complications. Dig Liver Dis (2006) 1.04
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double-blind placebo-controlled study. Aliment Pharmacol Ther (2002) 1.04
Exercise training restores ischemic preconditioning in the aging heart. J Am Coll Cardiol (2000) 1.04
Tandem action of exercise training and food restriction completely preserves ischemic preconditioning in the aging heart. Exp Gerontol (2005) 1.04
Myeloablative therapy and bone marrow rescue in advanced neuroblastoma. Report from the Italian Bone Marrow Transplant Registry. Italian Association of Pediatric Hematology-Oncology, BMT Group. Bone Marrow Transplant (1996) 1.03